{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:49:49Z","timestamp":1784224189937,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N028767\/1"],"award-info":[{"award-number":["MR\/N028767\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022661","name":"European Brain Council","doi-asserted-by":"publisher","award":["551578"],"award-info":[{"award-number":["551578"]}],"id":[{"id":"10.13039\/501100022661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000346","name":"Ataxia UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000346","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.heliyon.2025.e42121","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T18:17:54Z","timestamp":1738174674000},"page":"e42121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of specialist ataxia centres with non-specialist services in terms of care access and organisation, health services resource utilisation and costs in Germany using patient-reported data"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2092-5073","authenticated-orcid":false,"given":"Julie","family":"Vallortigara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2876-4849","authenticated-orcid":false,"given":"Julie","family":"Greenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holm","family":"Graessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Reinhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Nadke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart-Jan","family":"Schuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Giunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4 Movement Disorders","key":"10.1016\/j.heliyon.2025.e42121_bib1","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1212\/CON.0000000000000362","article-title":"Ataxia","volume":"22","author":"Ashizawa","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.heliyon.2025.e42121_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.gaitpost.2017.11.024","article-title":"A systematic review of the gait characteristics associated with Cerebellar Ataxia","volume":"60","author":"Buckley","year":"2018","journal-title":"Gait Posture"},{"key":"10.1016\/j.heliyon.2025.e42121_bib3","first-page":"1","article-title":"Epidemiology of inherited cerebellar ataxias and challenges in clinical research","author":"Pilotto","year":"2018","journal-title":"Clin. Transl. Neurosci."},{"key":"10.1016\/j.heliyon.2025.e42121_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117082","article-title":"Natural history and epidemiology of the spinocerebellar ataxias: insights from the first description to nowadays","volume":"417","author":"Scott","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"8\u20139","key":"10.1016\/j.heliyon.2025.e42121_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.neurol.2016.07.003","article-title":"Movement disorders in mitochondrial diseases","volume":"172","author":"Tranchant","year":"2016","journal-title":"Rev. Neurol. (Paris)"},{"issue":"14","key":"10.1016\/j.heliyon.2025.e42121_bib6","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.1073\/pnas.94.14.7452","article-title":"Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and permutations","volume":"94","author":"Coss\u00e9e","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2025.e42121_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jnc.12215","article-title":"Prevalence gradients of Friedreich's ataxia and R1b haplotype in Europe co-localize, suggesting a common Palaeolithic origin in the Franco-Cantabrian ice age refuge","volume":"126","author":"Vankan","year":"2013","journal-title":"J. Neurochem."},{"issue":"17","key":"10.1016\/j.heliyon.2025.e42121_bib8","doi-asserted-by":"crossref","DOI":"10.12968\/bjon.2006.15.17.21908","article-title":"Centres of excellence for the care of people with progressive ataxias","volume":"15","author":"Greenfield","year":"2006","journal-title":"Br. J. Nurs."},{"key":"10.1016\/j.heliyon.2025.e42121_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.12968\/bjnn.2008.4.11.31698","article-title":"Centres of excellence for the care of people with progressive ataxias","volume":"4","author":"Greenfield J","year":"2008","journal-title":"Br. J. Neurosci. Nurs."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e42121_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13023-019-1013-9","article-title":"Guidelines on the diagnosis and management of the progressive ataxias","volume":"14","author":"De Silva R","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.heliyon.2025.e42121_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13023-014-0184-7","article-title":"Clinical management guidelines writing group, consensus clinical management guidelines for Friedreich ataxia","volume":"9","author":"Corben","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.heliyon.2025.e42121_bib12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fncel.2018.00188","article-title":"Novel Nrf2-inducer prevents mitochondrial defects and oxidative stress in Friedreich's ataxia models","volume":"12","author":"Abeti","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.heliyon.2025.e42121_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.molmed.2023.12.002","article-title":"Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia","volume":"30","author":"Pilotto","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.heliyon.2025.e42121_bib14","unstructured":"European Medicine Agency, Science Medicines Health, Skyclarys. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/skyclarys."},{"issue":"2","key":"10.1016\/j.heliyon.2025.e42121_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3325\/cmj.2019.60.156","article-title":"Toward earlier diagnosis and treatment of rare neurological disorders: the value of coordinated care and specialist centers","volume":"60","author":"Giunti","year":"2019","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.heliyon.2025.e42121_bib16","unstructured":"DRN-RND: German Reference Network for Rare Neurological Diseases. https:\/\/se-atlas.de\/map\/drn\/Deutsches%20Referenznetzwerk%20f%C3%BCr%20Seltene%20Neurologische%20Erkrankungen?ln=en_EN."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e42121_bib17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s13023-023-02907-y","article-title":"Patient pathways for rare diseases in Europe: ataxia as an example","volume":"18","author":"Vallortigara","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e42121_bib18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s13023-023-02971-4","article-title":"Impact of specialist ataxia centres on health service resource utilisation and costs across Europe: cross-sectional survey","volume":"18","author":"Morris","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.heliyon.2025.e42121_bib19","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s10198-020-01229-1","article-title":"Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy","volume":"21","author":"P\u00f6hlmann","year":"2020","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.heliyon.2025.e42121_bib20","series-title":"Stata Statistical Software: Release 15","year":"2017"},{"issue":"9","key":"10.1016\/j.heliyon.2025.e42121_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-084865","article-title":"Comparison of specialist ataxia centres with non-specialist services in terms of treatment, care, health services resource utilisation and costs in the UK using patient-reported data","volume":"14","author":"Vallortigara","year":"2024","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.heliyon.2025.e42121_bib22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/WCO.0000000000000774","article-title":"Cerebellar ataxias: an update","volume":"33","author":"Manto","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.heliyon.2025.e42121_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.rare.2024.100018","article-title":"Rare disease care in Europe \u2013 gaping unmet needs","volume":"2","author":"Pakter","year":"2024","journal-title":"Rare"},{"key":"10.1016\/j.heliyon.2025.e42121_bib24","unstructured":"National Ataxia Foundation, Ataxia Centers of Excellence. https:\/\/www.ataxia.org\/ace\/."},{"key":"10.1016\/j.heliyon.2025.e42121_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1172-8-38","article-title":"Impact of Friedreich's Ataxia on health-care resource utilization in the United Kingdom and Germany","volume":"8","author":"Giunti","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.heliyon.2025.e42121_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.616569","article-title":"The European reference network for rare neurological diseases","volume":"11","author":"Reinhard","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.heliyon.2025.e42121_bib27","unstructured":"ParkinsonNet. https:\/\/www.parkinsonnet.com\/."},{"key":"10.1016\/j.heliyon.2025.e42121_bib28","unstructured":"European Reference Network, Neurological Diseases (ERN-RND). https:\/\/www.ern-rnd.eu\/."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844025005018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844025005018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:32:50Z","timestamp":1775737970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844025005018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2405844025005018"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42121","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of specialist ataxia centres with non-specialist services in terms of care access and organisation, health services resource utilisation and costs in Germany using patient-reported data","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e42121"}}